Integrated Filing — IndAS



General information about company

Scrip Code 543664
NSE Symbol KAYNES
MSEI Symbol NOTLISTED
ISIN INE918Z01012
Name of company KAYNES TECHNOLOGY INDIA LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 13-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 04-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Electronics Manufaturing Services
Start date and time of board meeting 13-05-2026   10:30:00
End date and time of board meeting 13-05-2026   15:45:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 1,24,263.80 3,62,635.40
Other income 4,185.80 15,683.00
Total income 1,28,449.60 3,78,318.40
2 Expenses
(a) Cost of materials consumed 92,088.70 2,54,222.20
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (7,236.90) (17,033.60)
(d) Employee benefit expense 9,075.90 31,355.40
(e) Finance costs 4,087.00 11,692.70
(f) Depreciation, depletion and amortisation expense 5,441.20 10,706.80
(f) Other Expenses
1 Other Expenses 10,966.40 36,685.90
Total other expenses 10,966.40 36,685.90
Total expenses 1,14,422.30 3,27,629.40
3 Total profit before exceptional items and tax 14,027.30 50,689.00
4 Exceptional items (4.00) (257.60)
5 Total profit before tax 14,023.30 50,431.40
6 Tax expense
7 Current tax 3,798.60 14,161.10
8 Deferred tax 1,102.40 (118.70)
9 Total tax expenses 4,901.00 14,042.40
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 9,122.30 36,389.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 9,122.30 36,389.00
17 Other comprehensive income net of taxes (789.20) 1,620.70
18 Total Comprehensive Income for the period 8,333.10 38,009.70
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 0.00 0.00
Total profit or loss, attributable to non-controlling interests 0.00 0.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 0.00 0.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 6,703.50 6,703.50
Face value of equity share capital 0 0
27 Details of debt securities
22 Reserves excluding revaluation reserve 4,68,131.80
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 13.32 54.85
Diluted earnings (loss) per share from continuing operations 13.23 54.45
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 13.32 54.85
Diluted earnings (loss) per share from continuing and discontinued operations 13.23 54.45
24 Debt equity ratio 0.1900 0.1900
25 Debt service coverage ratio 4.6900 5.7200
26 Interest service coverage ratio 5.7600 6.2300
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes : 1 The above statement of audited standalone and consolidated financial results (the Statements) of Kaynes Technology India Limited ('the Company') for the quarter and the year ended 31st March 2026 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on 13th May 2026. These statements have been subjected to audit by the Statutory Auditor of the Company. The reports of the Statutory Auditor are unqualified. 2 The consolidated financial statements include the financial results of Kaynes Technology India Limited (Parent Company) and of the following subsidiaries: i. Kaynes International Design & Manufacturing Private Limited ii. Kemsys Technologies Private Limited iii. Kaynes Electronics Manufacturing Private Limited iv. Kaynes Technology Europe Gmbh v. Kaynes Embedded Systems Private Limited vi. Kaynes Semicon Private Limited vii. Kaynes Circuits India Private Limited viii. Kaynes Mechatronics Private Limited ix. Digicom Electronics Inc. x. Essnkay Electronics LLC xi. Kaynes Holding Pte. Limited xii. Gridcrest Technologies Private Limited (Formerly Iskraemeco India Private Limited) xiii. Sensonic GmBH (Subsidiary of Kaynes Holding Pte. Limited) xiv. Sensonic-UK Limited (Subsidiary of Kaynes Holding Pte. Limited) xv. Sensonic IN India Private Limited (Subsidiary of Kaynes Holding Pte. Limited) xvi. Sensonic US Inc. (Subsidiary of Kaynes Holding Pte. Limited) xvii. August Electronics Inc. (Subsidiary of Kaynes Holding Pte. Limited) xviii Kaynes Space Technology Private Limited xix. Aerocaliph Components Private Limited xx. Cryo Precision Technologies Private Limited The Company and the Subsidiaries are collectively referred to as 'The Group'. 3 The Statements have been prepared in accordance with Indian Accounting Standards (‘Ind AS’) prescribed under Section 133 of the Companies Act, 2013 and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 4 On November 21, 2025, the Government of India notified the four Labour Codes - the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020, and the Occupational Safety, Health and Working Conditions Code, 2020 - consolidating 29 existing labour laws. The Ministry of Labour & Employment published draft Central Rules and FAQs to enable assessment of the financial impact due to changes in regulations. The Company has assessed and disclosed the incremental impact of these changes on the basis of information available, consistent with the guidance provided by the Institute of Chartered Accountants of India. Considering the materiality and regulatory-driven, non-recurring nature of this impact, the Company has presented such incremental impact as impact of new Labour Codes under Exceptional Items in the financial results for the quarter and the year ended March 31, 2026. Pursuant to the implementation, defined benefit obligations have increased by Rs. 25.54 million in the standalone financial statements and Rs. 25.76 million in the consolidated financial statements, which has been recognised as employee exceptional Items for the current reporting period. The Company continues to monitor the finalisation of Central / State Rules and clarifications from the Government on other aspects of the Labour Code and would provide appropriate accounting effect on the basis of such developments as needed. 5 The Company has completed its IPO of 14,613,624 equity shares of face value of Rs. 10/- each at an issue price of Rs. 587 per equity share, comprising 9,028,960 fresh shares and offer for sale of 5,584,664 shares by selling share holders. In addition to above, the Company has raised Rs. 1,300 million by issue of 2,338,760 equity shares at a price of Rs. 555.85 per equity share, by way of Pre-IPO placement. The equity shares of the company were listed on NSE Limited and BSE Limited on November 22, 2022. The Company has estimated Rs. 547.97 million as IPO related expenses and allocated such expenses between the Company and selling shareholders in proportion to the total proceeds raised as stated above, amounting to Rs. 348.99 million and Rs. 198.98 million respectively. The Company's share of Rs. 348.99 million was adjusted against the Securities Premium. 6 The Company has received Rs. 6,238.69 million (net of IPO expense of Rs. 342.56 million and unbudgeted IPO expenses of Rs. 18.75 million) from the proceeds of fresh issue of equity shares. The utilisation of net IPO proceeds is summarised below: Objects of the issue as per prospectus Amount to be utilised as per Prospectus Utilisation up to 31st March 2026 Unutilised as on 31st March 2026 Repayment/ prepayment, in full or part, of certain borrowings availed by our Company 1,300.00 1,300.00 - Funding capital expenditure towards expansion of our existing manufacturing facility at Mysuru, Karnataka, and near our existing manufacturing facility at Manesar, Haryana 989.30 989.30 - Investment in our wholly owned Subsidiary, Kaynes Electronics Manufacturing Private Limited, for setting up a new facility at Chamarajanagar, Karnataka 1,493.00 1,493.00 - Funding working capital requirements of our Company 1,147.40 1,147.40 - General corporate purposes 1,327.74 1,327.74 - Total 6,257.44 6,257.44 - 7 The company has raised a capital of Rs. 14,000 million through Qualified Institutional Placement (QIP) of equity shares, the fund raising committee of the Board of Directors of the company at its meeting held on December 21, 2023 approved the allotment of 57,75,577 equity shares of face value of Rs. 10/- each at an issue price of Rs. 2,424.00 per equity share (including a premium of Rs. 2,414.00 per equity share). 8 The Company has estimated Rs. 260.00 million as QIP related expenses (inclusive of GST) and fully allocated such expenses to the Company. An amount Rs. 201.05 million was adjusted against the Securities Premium. The Company has received Rs. 13,740 million (net of QIP expense of Rs. 260.00 million) from the proceeds of fresh issue of equity shares. The utilisation of net QIP proceeds is summarised below: Particulars Amount to be utilised as per Placement Document Utilisation up to 31st March 2026 Unutilised as on 31st March 2026 Part funding the cost of establishment of the OSAT facility 7,567.11 6,249.79 1,317.32 Part funding the cost of establishment of the PCB facility 3,072.89 3,072.89 - General corporate purpose(1) 3,100.00 3,100.00 - Total Net Proceeds 13,740.00 12,422.68 1,317.32 (1) the amount to be utilised for general corporate purpose alone should not exceed 25% of the gross proceeds The Net QIP proceeds which were unutilised as at 31st March 2026 were temporarily invested in deposits with Scheduled commercial banks. 9 The company has raised a capital of Rs. 16,000 million through Qualified Institutional Placement (QIP) of equity shares, the fund raising committee of the Board of Directors of the company at its meeting held on June 24, 2025 approved the allotment of 28,72,788 equity shares of face value of Rs. 10/- each at an issue price of Rs. 5,569.50 per equity share (including a premium of Rs. 5,559.50 per equity share). 10 The Company has estimated Rs. 250.34 million as QIP related expenses (inclusive of GST) and fully allocated such expenses to the Company. This amount Rs. 250.34 million will be adjusted against the Securities Premium. The Company has received Rs. 15,749.66 million (net of QIP expense of Rs. 250.34 million) from the proceeds of fresh issue of equity shares. The utilisation of net QIP proceeds is summarised below: Particulars Amount to be utilised as per Placement Document Utilisation up to 31st March 2026 Unutilised as on 31st March 2026 Particulars 8,412.61 8,412.61 - Funding of working capital requirements of our Company 2,000.00 2,000.00 - Funding of inorganic growth opportunities, including but not limited to acquisitions, strategic investments, and joint ventures 1,600.00 1,228.42 371.58 General corporate purpose(1) 3,737.05 2,233.29 1,503.76 Offer expenses 250.34 235.15 15.19 Total Net Proceeds 16,000.00 14,109.47 1,890.53 (1) the amount to be utilised for general corporate purpose alone should not exceed 25% of the gross proceeds The Net QIP proceeds which were unutilised as at 31st March 2026 were temporarily invested in deposits with Scheduled commercial banks and Mutual Funds. 11 During the quarter, the company has acquired 76% stake in Aerocaliph Components Private Limited and Cryo Precision Technologies Private Limited. Both the companies primarily operate in the Electronics System Design and Manufacturing (ESDM) Segment. 12 The Group primarily operate in the Electronics System Design and Manufacturing (ESDM) Segment. 13 Prior period/ year figures have been reclassified wherever required to conform to the classification of the current period/ year.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 1,10,972.80
Capital work-in-progress 37,241.10
Investment property 0.00
Goodwill 1,607.90
Other intangible assets 38,195.40
Intangible assets under development 13,832.10
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 25,705.20
Trade receivables, non-current
Loans, non-current 1,624.20
Other non-current financial assets
1 Other non-current financial assets 128.60
Total of other non-current financial assets 128.60
Total non-current financial assets 27,458.00
Deferred tax assets (net)
Other non-current assets
1 Other non-current assets 66,730.10
2 Rights-of-Use Assets 8,635.20
Total of other non-current assets 75,365.30
Total non-current assets 3,04,672.60
2 Current assets
Inventories 1,10,322.70
Current financial asset
Current investments 0.00
Trade receivables, current 1,52,761.50
Cash and cash equivalents 10,942.90
Bank balance other than cash and cash equivalents 68,916.20
Loans, current 520.10
Other current financial assets
Total of other current financial assets 2,655.70
Total current financial assets 2,35,796.40
Current tax assets (net) 113.50
Other current assets
1 Other current assets 38,496.30
Total of other current assets 38,496.30
Total current assets 3,84,728.90
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 6,89,401.50
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 6,703.50
Other equity 4,68,131.80
Total equity attributable to owners of parent 4,74,835.30
Non controlling interest 1,413.50
Total equity 4,76,248.80
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 33,699.80
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease Liabilities 3,201.10
Total of other non-current financial liabilities 3,201.10
Total non-current financial liabilities 36,900.90
Provisions, non-current 0.00
Deferred tax liabilities (net) 1,851.40
Deferred government grants, Non-current
Other non-current liabilities
1 Long Term Provisions 1,674.80
Total of other non-current liabilities 1,674.80
Total non-current liabilities 40,427.10
Current liabilities
Current financial liabilities
Borrowings, current 53,794.10
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 10,773.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 74,302.80
Total Trade payable 85,075.80
Other current financial liabilities
1 Other current financial liabilities 14,476.90
2 Lease Liabilities 592.30
Total of other current financial liabilities 15,069.20
Total current financial liabilities 1,53,939.10
Other current liabilities 18,685.60
1 Other current liabilities 18,685.60
Total of other current liabilities 18,685.60
Provisions, current 100.90
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 1,72,725.60
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 2,13,152.70
Total equity and liabilites 6,89,401.50
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss 268.70 (2,165.90)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 520.50 545.20
5 Total Other comprehensive income (789.20) 1,620.70



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 50,431.40
Adjustments for reconcile profit (loss)
Adjustments for finance costs 11,399.80
Adjustments for decrease (increase) in inventories (28,880.40)
Adjustments for decrease (increase) in trade receivables, current (1,02,386.60)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (14,252.60)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 31,780.40
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 515.70
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 10,706.80
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 7,820.80
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (737.70)
Adjustments for dividend income 0.00
Adjustments for interest income 10,114.30
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (566.30)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) (2,385.90)
Other adjustments for non-cash items 616.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (96,484.30)
Net cash flows from (used in) operations (46,052.90)
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 13,987.50
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (60,040.40)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 2,906.60
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 6,871.60
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 1,24,030.10
Proceeds from sales of investment property 31,972.20
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 10,114.30
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) investing activities (91,721.80)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 1,60,156.20
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 9,206.50
Repayments of borrowings 0.00
Payments of lease liabilities 0.00
Dividends paid 0.00
Interest paid 11,399.80
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 1,57,962.90
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 6,200.70
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 6,200.70
Cash and cash equivalents cash flow statement at beginning of period 4,742.20
Cash and cash equivalents cash flow statement at end of period 10,942.90





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 KP Rao & Co Yes 30-04-2027